RE:RE:Good News Canadian Biotech StoryAlso, TRIL worth $1.45 B and only slightly ahead of TH with oncology clinical trials and generating almost no income.
I found it interesting that AUP is going to market their drug themselves instead of partnering with big pharma. Maybe that is Thera's intention too. Though many years down the road.
Adonis wrote: AUPH has no revenue yet, last quarter reported $ 0.3 million I think I can't understand how it has a market cap of 1.9 billion and THTX which said almost $ 70 million has a cap of $ 200 million ..